KITE
Kite Pharma, Inc.
Director Roy Doumani sold $1.3M of Kite Pharma, Inc.
Sold$1,267,255
$84.48Price
15,000Shares
−8%Stake
What KITE did after the filing
Prices for KITE after this filing aren't in yet.
Traded Wed, Jun 7. Filed Fri, Jun 9, 5:11 PM ET, after the close. Not investment advice.